Back
Innovate Vs. Insmed Industry Stock Comparison
Sell
24
VATE
Innovate
Last Price:
$5.36
Seasonality Move:
-11.75%
Buy
61
INSM
Insmed
Last Price:
$99.50
Seasonality Move:
-2.96%
Sell
24
Innovate (VATE)
is a Sell
Is Innovate a Buy, Sell or Hold?
-
VATE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INSM Stock Price Chart
VATE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 44.12 | Sell |
Chaikin Money Flow: | 31571 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.16 - 6.22) | Sell |
Bollinger Bands (100): | (5.21 - 9.83) | Sell |
INSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.47 | Buy |
Relative Strength Index (14 RSI): | 66.29 | Buy |
Chaikin Money Flow: | -15708121 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (70.46 - 101.42) | Buy |
Bollinger Bands (100): | (66.65 - 87.33) | Buy |
VATE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.28 | Buy |
20-day SMA: | 5.46 | Sell |
50-day SMA: | 5.97 | Sell |
200-day SMA: | 6.46 | Sell |
8-day EMA: | 5.31 | Buy |
20-day EMA: | 5.51 | Sell |
50-day EMA: | 6.03 | Sell |
200-day EMA: | 6.85 | Sell |
INSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102.48 | Sell |
20-day SMA: | 90.56 | Buy |
50-day SMA: | 77.52 | Buy |
200-day SMA: | 74.62 | Buy |
8-day EMA: | 100.8 | Sell |
20-day EMA: | 92.85 | Buy |
50-day EMA: | 82.88 | Buy |
200-day EMA: | 72.59 | Buy |
Innovate Earnings Growth & VATE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Insmed Earnings Growth & INSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $1.61 per share.
Innovate Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Insmed Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |